Rallis India Ltd Q2 FY2023 Concall Summary

Source transcript PDF: https://assets.stockscans.in/docs/enjbjxz19f4d0nn7ikrzxpev.pdf

Key Takeaways


Domestic Business: A Monsoon-Driven Miss

Sanjiv Lal: "Last year, we have seen a fairly large roll-over of inventory into H2. And it is our assessment that there's going to be a lot of rollover of inventory of all agrochemical companies into H2 as well. So there is going to be a considerable amount of pressure in terms of liquidation of agrochemicals in the market."

International Business: Strong Volumes, Weaker Pricing

S. Nagarajan: "As you would appreciate, the combination of the products that we sell and the markets where we sell, that is really the combination that can determine the level of pricing flexibility that we could have."

Margins: Holding the Line While Clearing Inventory

Sanjiv Lal: "More or less, we have tried to work down our high-cost inventory. So I think we are in a much better position today than what we were maybe three months back because we have had to take some lower margins, especially for liquidating some of the high-cost inventory that we were holding."

Working Capital & Receivables: Stress on Both Fronts


Seeds Business: Restructuring Underway, More Pain Possible


Strategic Initiatives: Building the Next Leg of Growth


Guidance & Commitments

CommitmentSpecificsTimeline
Business pickupHigher reservoir levels and good soil moisture to aid Rabi season; remunerative global agri commodity prices to aid international businessH2 FY23
PEKK shipments resumeOrders coming back; shipments to commenceQ4 FY23
New CM contracts reach scaleTwo contract manufacturing wins to generate meaningful revenue after customer registrations complete2–3 years
Local sourcing targetOne intermediate to reach 80% local sourcing, up from 0% previously; another intermediate to reach 20% local sourcingBy year-end FY23
Crop Nutrition growthAt least 20% growth targeted for the categoryCurrent year (FY23)
Export revenue shareExports to reach ~40% of Crop Protection revenue, driven by manufacture-led exports and new AIsBy FY26
MPP revenue startNew multi-purpose plant commissioning; revenue streams to begin and scale thereafterCommissioning Q4 FY23; revenue from FY24, scaling FY25+
Seeds restructuring provisionsAdditional inventory and other provisions may be necessitated as cost review continuesDuring FY23
Interim debtMay require additional short-term borrowings; not expected to exceed ₹50–100 crore increaseBy year-end FY23
Diggaz cotton hybrid scalingTargeting doubling of salesNext Kharif season

Key Metrics

MetricQ2 FY23
Revenue₹951 cr, +31% YoY
Domestic business revenue₹608 cr, +18.2% YoY, volume growth in low single-digits
International business revenue growth+67.4% YoY, driven by both volume and value
Seeds business revenue₹28 cr
EBITDA₹118 cr, vs ₹88 cr in Q2 FY22
EBITDA margin12.4%, +30 bps YoY
Profit after tax₹71 cr, +26% YoY
Crop Nutrition revenue (FY22 full year)~₹145 cr, outlooking at least 20% growth in FY23
Formulated products share of export business~20%
International business share of Crop Protection revenue33–35%, expected to reach ~40% by FY26
Diggaz cotton hybrid packets sold1.7 lakh packets, vs 20,000 in previous year
Seeds business inventory provisions (H1 FY23)₹25 cr
Capex spent in H1 FY23~₹100 cr, out of ₹250 cr planned for the year
Metribuzin revenue growth (H1 FY23 vs H1 FY22)>60%
Pendimethalin revenue growth (H1 FY23 vs H1 FY22)>20%
Acephate plant utilization100%
Pendimethalin plant utilization~90%
Pendimethalin capacity~5,000 tonnes per year
Metribuzin capacity~3,000 tonnes per year
International debtors days on hand30–40% higher vs previous year
PEKK shipmentsRestarting in Q4 FY23, after a gap of 2 years